Whither or wither microbicides?

Science

Volumn 321, Issue 5888, 2008, Pages 532-534

  Grant, Robert M ^a   Hamer, Dean ^b   Hope, Thomas ^c   Johnston, Rowena ^d   Lange, Joep ^e   Lederman, Michael M ^f   Lieberman, Judy ^g   Miller, Christopher J ^h   Moore, John P ⁱ   Mosier, Donald E ^j   Richman, Douglas D ^k   Schooley, Robert T ^k   Springer, Marty S ^l   Veazey, Ronald S ^m   Wainberg, Mark A ⁿ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Amer Foundation for AIDS Research   (United States)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

^j SCRIPPS RESEARCH INSTITUTE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l MERCK RESEARCH LABORATORIES   (United States)

^m TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

ⁿ MCGILL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CELLULOSE SULFATE; DODECYL SULFATE SODIUM; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTEGRASE INHIBITOR; MICROBICIDE; NEVIRAPINE; POLYANION; PRO 2000; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIMICROBIAL ACTIVITY; DISEASE TRANSMISSION; DISEASE TREATMENT; HUMAN IMMUNODEFICIENCY VIRUS; MODELING;

DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SHORT SURVEY; VIRUS RESISTANCE; VIRUS TRANSMISSION;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PATIENT COMPLIANCE; POLYMERS; PRIMATES; REVERSE TRANSCRIPTASE INHIBITORS; VAGINAL DISEASES;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 48249121565     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1160355     Document Type: Short Survey

References (21)

1. Microbicides Development Programme Update; www.mdp.mrc.ac.uk/downloads/ MDP_statement_14Feb08_v1[1].2_FINAL.pdf.
2. J. H. van de Wijgert, R. J. Shattock, AIDS 21, 2369 (2007).
3. S. L. Hillier et al., J. Acquir. Immune Defic. Syndr. 39, 1 (2005).
4. P. J. Feldblum et al., PLoS One 3, e1474 (2008).
5. M. Moulard et al., J. Virol. 74, 1948 (2000).
6. R. J. Shattock, R. W. Doms, Nat. Med. 8, 425 (2002).
7. W. Tao, C. Richards, D. Hamer, AIDS Res. Hum. Retroviruses 24 (7) (2008); epub ahead of print, DOI: 10.1089/aid.2008.0043.
8. C. Flexner et al., Antimicrob. Agents Chemother. 35, 2544 (1991).
9. P. R. Meylan, R. S. Kornbluth, I. Zbinden, D. D. Richman, Antimicrob. Agents Chemother. 38, 2910 (1994).
10. H. Ward, A. De La Court, V. Kitchen, Sex. Transm. Dis. 23, 413 (1996).
11. M. K. Stafford et al., J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17, 327 (1998).
12. P. J. Klasse, R. Shattock, J. P. Moore, Annu. Rev. Med. 59, 455 (2008).
13. E. De Clercq, Chem. Biodivers. 1, 44 (2004).
14. J. Martinez, P. Coplan, M. A. Wainberg, Antiviral Res. 71, 343 (2006).
15. A. S. Duran et al., AIDS 21, 199 (2007).
16. M. M. Lederman, R. E. Offord, O. Hartley, Nat. Rev. Immunol. 6, 371 (2006).
17. M. Saag et al., 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention (22 to 25 July 2007, Sydney), abstract WESS104.
18. J. Heera et al., 15th Conference on Retroviruses and Opportunistic Infections (3 to 6 February 2008, Boston), abstract 40LB.
19. P. M. Coplan, M. Mitchnick, Z. F. Rosenberg, Science 304, 1911 (2004).
20. J. Cohen, Science 319, 1026 (2008).
21. K. Malcolm, D. Woolfson, C. Toner, D. Lowry, Biotechnol. Genet. Eng. Rev. 21, 81 (2004).